Global AI-Based Surgical Robots Market is expected to foresee significant growth during the forecast period. North America to witness the highest growth

Global AI-Based Surgical Robots Market is expected to reach the market valuation of US$ XX million by 2027 expanding at a reasonable CAGR of XX% during the forecast period (2021-2027) from US$ XX million in 2019. They are primarily used in gynecological, urological, orthopedic, general, neurosurgeries, and other minimally invasive surgeries. Growth in this market is primarily driven by the advantages of robotic-assisted surgery, technological advancements in surgical robots, the increasing adoption of surgical robots, and the increase in funding for medical robot research.

Ambulatory surgery centers (ASCs) are freestanding facilities specializing in surgical, diagnostic, and preventive procedures that do not require hospital admission. The cost-effectiveness of ASCs provides significant savings for governments, third-party payers, and patients. A study conducted by Healthcare BlueBook (a provider of data for healthcare services) and HealthSmart (a provider of health plans for self?funded employers) concluded that ASCs decreased the cost of outpatient surgery by USD 38 billion annually since these facilities offer a lower-cost site of care compared to hospital outpatient departments.

For a detailed analysis of the market drivers in AI-Based Surgical Robots browse through -

Medicare and its beneficiaries save more than USD 2.6 billion each year because they pay significantly less for procedures performed in ASCs than the rates paid to hospitals for the same procedures. Patient co-payments are also significantly lower when care is received in an ASC. Owing to these cost benefits, there has been a rapid increase in the number of surgical procedures performed in ASCs and outpatient settings, while hospital in-patient visits have reduced. According to a 2019 article in the ASC Focus journal, Ambulatory Surgery Center Association, there has been a significant shift from performing complex surgical procedures in hospital settings to performing them in outpatient settings.

Owing to this, ASCs, especially in the US, are increasingly acquiring advanced robotics to treat complex cases. The Atlanta Minimally Invasive Gynecologic Surgery Center, Health East Ambulatory Surgical Center, and Hutchinson Ambulatory Surgery Center are some ASCs that employ the da Vinci Surgical System to perform minimally invasive procedures. Midtown Surgery Center and San Francisco Surgery Center also offer MAKOplasty, a robotic-arm guided procedure for orthopedic treatment. Thus, the growing number of ASCs providing robotic-assisted specialized surgeries provides an enormous opportunity for players in the surgical robots market.

The demand for minimally invasive surgeries (MIS) is on the rise mainly due to the advantages associated with these procedures, such as smaller incisions, fewer cuts, decreased scarring, reduced pain, increased safety, faster recovery periods, and considerable cost savings. Robotic minimally invasive surgery adds to these advantages by ensuring greater accuracy, repeatability, control, and efficiency.

For a detailed analysis of the COVID-19 Impact on AI-Based Surgical Robots browse through -

According to a 2020 article on the comparison of surgical outcomes between integrated robotic and conventional laparoscopic surgery for distal gastrectomy, the surgical success rate in the IRDG (integrated robotic distal gastrectomy) group was 98.0%; significantly higher as compared to the CLDG (conventional laparoscopic distal gastrectomy) group, which accounted for 89.5% success rate. Though the incidence of in-patient and outpatient complications was similar between the groups, the readmission rate in the IRDG group (98.0%) was significantly lower than in the CLDG group (84.3%).

Robotic surgery also offers highly advanced visualization capabilities that provide surgeons with a superior view of the operating area, using HD cameras to illustrate microscopic structures. These systems provide greater dexterity than the human hand; given their ability to rotate 360 degrees and superior maneuverability, robots can allow surgeons to reach hard-to-access areas. These advantages of surgical robots and the rising demand for better, quicker healthcare services are expected to drive the growth of the overall surgical robots market in the coming years. For instance, In January 2021, TransEnterix received CE Mark approval for its Intelligent Surgical Unit that adds AI-based capabilities and enables machine vision capabilities on the TransEnterix’s Senhance robotic surgery system.

For a detailed analysis of the Product Type in AI-Based Surgical Robots browse through -

The COVID-19 pandemic has had a devastating global impact on the world’s population and economy. The pandemic has put a significant strain on healthcare systems. During this period, healthcare institutions and providers have been instructed to stop performing elective surgical procedures and medical examinations to minimize the possibility of transmission and conserve healthcare resources for COVID-19 patients. The pandemic has led to a temporary ban on elective surgeries across the globe, which resulted in the cancellations of elective surgeries worldwide posing a negative impact on the globe. For Instance: In January 2021, Stryker acquired OrthoSensor and its Verasense intraoperative sensor tech to enhance the ortho giant’s Mako robots.

Based on Product, the services segment dominated the market for AI-based surgical robots and accounted for the largest revenue share of XX % in 2020. This high share is attributable to the higher cost of maintenance associated with the algorithms of robot-assisted surgery systems. Furthermore, routine technological upgrades and comprehensive service contracts provided to customers by many companies further increases the revenue share.

For a detailed analysis of the Application in AI-Based Surgical Robots browse through -

Based on application, the others segment dominated the market for AI-based surgical robots and accounted for the largest revenue share of XX% in 2020. Other applications mainly include general surgeries, laparoscopy, and ophthalmology, and oncology surgeries. The factors contributing to the high revenue share of the segment include increasing abdominal and oncology-based surgical procedures, coupled with the rising prevalence of breast cancer. In addition, the growing adoption of robots for minimally invasive laparoscopic procedures by surgeons further signifies a higher share.

Global AI-Based Surgical Robots Market Segmentation

Market Insight, by Product Type

  • Services
  • Instruments
  • Accessories

Market Insight, by Application

  • Orthopedics
  • Neurology
  • Urology
  • Gynecology
  • Others

Market Insight, by End User

  • Hospitals
  • Ambulatory Surgical Centers

Market Insight, by Region

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • France
    • Germany
    • Spain
    • Italy
    • United Kingdom
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Rest of World

Top Company Profiles

  • Accuray Incorporated
  • Intuitive Surgical, Inc.
  • Medtronic, plc
  • Medrobotics Corporation
  • Zimmer Biomet
  • Stereotaxis, Inc.
  • TransEnterix, Inc. (Asensus Inc.)
  • Stryker Corporation
  • Activ Surgical, Inc.
  • Titan Medical, Inc.
  • CMR Surgical, Inc.
  • Smith and Nephew